- There will be no cure for type 1 within the next 10 years. Through hope and optimistic characterizations, the current establishment has created a mindset with donors that a cure is on the horizon. An independent analysis of the data supports our assertion that there will be no cure within the next ten years.
- We need an objective measurement system with integrity to assess progress in finding a cure. The major type 1 fund-raising organizations have developed sophisticated, objective based fund-raising systems but not an objective based system that measures progress towards a cure.
- The real source of funding is from people who are seeking a cure – not treatments for complications or general research. The industry’s efforts are not aligned with that desire.
- Unless you create a demand for a cure that is date certain, you will not get a focused response that is targeting a specific date.
- People’s innate gratitude that there is a charity to help fight for the cure has forestalled a healthy demand for accountability to donors. Donors are just happy to be contributing to the fight and not asking the questions one normally would in a natural business relationship. This in turn causes the charity to not be as effective and efficient as it should be.
- Type 1 funding and research should not align itself with type II disease and community. The idea that type 1 can benefit from type 2 because type II is 10 times more prevalent is a myth. These are totally different diseases and provides false hope, justifies non-cure related findings, and hinders progress towards a cure for type I.
- We believe the cure will come from overwhelming support for a small, select group of initiatives versus a modest level of support for a large number of different projects. (e.g. The largest research foundation is currently funding 700+ projects)
- We are scientifically agnostic. It is not our role to find a cure but to evaluate and analyze the likelihood that a particular organization and approach may reach the goal of finding a cure. This analysis will assist direct donors to make contributions to organizations/projects that maximize the chance that a cure will be found